Test ID: MSH2M
MSH2 Mutation Screen
Secondary ID
A test code used for billing and in test definitions created prior to November 2011
83016
NY State Approved
Indicates the status of NY State approval and if the test is orderable for NY State clients.
Yes
Useful For
Suggests clinical disorders or settings where the test may be helpful
Determining whether absence of MSH2 protein, by immunohistochemistry in tumor tissue, is associated with a germline mutation in the affected individual
Establishing a diagnosis of Lynch syndrome/hereditary nonpolyposis colorectal cancer
Identification of familial MSH2 mutation to allow for predictive testing in family members
Testing Algorithm
Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
See Hereditary Nonpolyposis Colorectal Cancer Testing Algorithm in Special Instructions.
Special Instructions and Forms
Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name
A short description of the method used to perform the test
Polymerase Chain Reaction (PCR) Followed by DNA Sequence Analysis and Gene Dosage Analysis by Multiplex Ligation-Dependent Probe Amplification (MLPA)
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name
A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
MSH2 Mutation Screen
Aliases
Lists additional common names for a test, as an aid in searching
Colon Cancer gene testing
Hereditary Nonpolyposis Colorectal Cancer (HNPCC)
hMSH2 genotyping
HNPCC (Hereditary Nonpolyposis Colorectal Cancer)
Lynch Syndrome
MSH2 gene testing
TACSTD1
EPCAM
Hereditary Nonpolyposis Colorectal Cancer (HNPCC)
hMSH2 genotyping
HNPCC (Hereditary Nonpolyposis Colorectal Cancer)
Lynch Syndrome
MSH2 gene testing
TACSTD1
EPCAM


